- China is reportedly investigating Sanofi (SNY) for allegedly paying bribes of 1.7M yuan ($277,600) to over 500 Chinese doctors in order to increase sales.
- The probe follows a report on Thursday in which a whistleblower accused the French pharmaceuticals company of making the payments.
- The inquiry also comes as authorities investigate GSK for bribery and amid visits to other foreign drug companies, including Novo Nordisk, AstraZeneca and Eli Lilly.
China investigating Sanofi for alleged bribery - report
Aug 11 2013, 01:50 ET